These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1448851)

  • 21. The effects of phenytoin and carbamazepine on serum concentrations of mono-unsaturated metabolites of valproic acid.
    Kondo T; Otani K; Hirano T; Kaneko S; Fukushima Y
    Br J Clin Pharmacol; 1990 Jan; 29(1):116-9. PubMed ID: 2105099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction in N-Desmethylclozapine Level Is Determined by Daily Dose But Not Serum Concentration of Valproic Acid-Indications of a Presystemic Interaction Mechanism.
    Smith RL; Kyllesø L; Haslemo T; Andreassen OA; Molden E
    Ther Drug Monit; 2019 Aug; 41(4):503-508. PubMed ID: 31259880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in the carnitine metabolism in epileptic children treated with valproic acid.
    Chung S; Choi J; Hyun T; Rha Y; Bae C
    J Korean Med Sci; 1997 Dec; 12(6):553-8. PubMed ID: 9443096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of binding equation method for prediction of unbound serum valproic acid concentration in pediatric patients with epilepsy.
    Kodama Y; Kuranari M; Kodama H; Koike Y; Yasunaga F; Fujii I; Takeyama M
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):114-8. PubMed ID: 7757310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum concentrations of rufinamide in children and adults with epilepsy: the influence of dose, age, and comedication.
    May TW; Boor R; Rambeck B; Jürgens U; Korn-Merker E; Brandt C
    Ther Drug Monit; 2011 Apr; 33(2):214-21. PubMed ID: 21383651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variability of phenytoin, carbamazepine and valproate concentrations in a clinic population.
    Leppik IE
    Epilepsy Res Suppl; 1988; 1():85-90. PubMed ID: 3149581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of age, gender and CYP2C9/2C19 genotypes on dose-adjusted steady-state serum concentrations of valproic acid-a large-scale study based on naturalistic therapeutic drug monitoring data.
    Smith RL; Haslemo T; Refsum H; Molden E
    Eur J Clin Pharmacol; 2016 Sep; 72(9):1099-104. PubMed ID: 27353638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic variability of valproate during pregnancy - Implications for the use of therapeutic drug monitoring.
    Johannessen Landmark C; Farmen AH; Burns ML; Baftiu A; Lossius MI; Johannessen SI; Tomson T
    Epilepsy Res; 2018 Mar; 141():31-37. PubMed ID: 29453075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of CYP2C9 and CYP2A6 on plasma concentrations of valproic acid: a meta-analysis.
    Yoon HY; Ahn MH; Yee J; Lee N; Han JM; Gwak HS
    Eur J Clin Pharmacol; 2020 Aug; 76(8):1053-1058. PubMed ID: 32385545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valproic acid free fraction in epileptic children under chronic monotherapy.
    Riva R; Albani F; Franzoni E; Perucca E; Santucci M; Baruzzi A
    Ther Drug Monit; 1983 Jun; 5(2):197-200. PubMed ID: 6410546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid function in children with epilepsy treated with sodium valproate monotherapy: a prospective study.
    Attilakos A; Katsarou E; Prassouli A; Mastroyianni S; Voudris K; Fotinou A; Garoufi A
    Clin Neuropharmacol; 2009; 32(1):32-4. PubMed ID: 18978499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methods.
    Kerrick JM; Wolff DL; Graves NM
    Ann Pharmacother; 1995 May; 29(5):470-4. PubMed ID: 7655129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concomitant therapy.
    Rosenfeld WE; Liao S; Kramer LD; Anderson G; Palmer M; Levy RH; Nayak RK
    Epilepsia; 1997 Mar; 38(3):324-33. PubMed ID: 9070595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The clinical relevance of serial determinations of plasma concentrations of carbamazepine and sodium valproate].
    Hernández-Fustes OJ; Marcourakis T; de Bittencourt PR
    Rev Neurol; 1999 Jun 1-15; 28(11):1043-7. PubMed ID: 10390769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic variability of valproate in women of childbearing age.
    Johannessen Landmark C; Burns ML; Baftiu A; Farmen AH; Lossius MI; Johannessen SI; Tomson T
    Epilepsia; 2017 Oct; 58(10):e142-e146. PubMed ID: 28833045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multivariable analysis of factors governing the steady-state pharmacokinetics of valproic acid in 52 young epileptics.
    Hall K; Otten N; Johnston B; Irvine-Meek J; Leroux M; Seshia S
    J Clin Pharmacol; 1985; 25(4):261-8. PubMed ID: 3924980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of age and co-medication on the steady-state pharmacokinetics of valproic acid in Tunisian patients with epilepsy.
    Ben Mahmoud L; Hakim A; Ghozzi H; Atheymen R; Sahnoun Z; Zeghal K
    Rev Neurol (Paris); 2017 Mar; 173(3):159-163. PubMed ID: 28320517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation.
    Ding J; Wang Y; Lin W; Wang C; Zhao L; Li X; Zhao Z; Miao L; Jiao Z
    Clin Pharmacokinet; 2015 Mar; 54(3):305-17. PubMed ID: 25388986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steady-state serum concentrations of carbamazepine and valproic acid in obese and lean patients with epilepsy.
    Suemaru K; Kawasaki H; Yasuhara K; Yao K; Furuno K; Kawakami Y; Araki H; Gomita Y; Oka E
    Acta Med Okayama; 1998 Jun; 52(3):139-42. PubMed ID: 9661740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased apparent oral clearance of valproic acid during intake of combined contraceptive steroids in women with epilepsy.
    Galimberti CA; Mazzucchelli I; Arbasino C; Canevini MP; Fattore C; Perucca E
    Epilepsia; 2006 Sep; 47(9):1569-72. PubMed ID: 16981874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.